PUBLIC CONTRACT · 2022
Medicamento exclusivo sanofi - Rasburicase 1,5MG e 7,5MG pó e solv conc sol inj fr IV (fasturtec)
- Contract value
- €16,680.71
- Signed on
- 2 September 2022
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 9536079PUBLISHED DESCRIPTION
AM/00000009/2022
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Aveiro, Aveiro
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Sanofi - Produtos Farmacêuticos, Lda · Tax ID 500134960
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €16,680.71
- Procedure base price
- €16,737.27
- Total effective price
- Not reported on Portal BASE
- Publication date
- 7 November 2022
- Award date
- 25 August 2022
- Signing date
- 2 September 2022
- Performance period
- 1,096 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Monofator
- CPV code
- 33690000-3 - Medicamentos vários
- Legal basis
- Artigo 24.º, n.º 1, alínea e), subalínea ii) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 6007926
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.